Complete Mole |
Absent or |
Complete |
---|---|---|
Heterogenous population of villi | absent |
0 (0.0) |
Circumferential trophoblastic proliferation | absent |
1 (12.5) |
Cytotrophoblastic proliferation | absent |
3 (37.5) |
Nuclear atypia | absent |
0 (0.0) |
Karyorrhectic stromal debris | absent |
6 (75 0) |
Positive Cells (%) | Ki-67 |
p63 |
p57 |
---|---|---|---|
0 | 0 (0.0) | 0 (0.0) | 8 (100) |
10 | 0 (0.0) | 0 (0.0) | 0 (0.0) |
20 | 0 (0.0) | 0 (0.0) | 0 (0.0) |
30 | 0 (0.0) | 0 (0.0) | 0 (0.0) |
40 | 0 (0.0) | 0 (0.0) | 0 (0.0) |
50 | 0 (0.0) | 0 (0.0) | 0 (0.0) |
60 | 0 (0.0) | 3 (37.5) | 0 (0.0) |
70 | 4 (50.0) | 2 (25.0) | 0 (0.0) |
80 | 3 (37.5) | 3 (37.5) | 0 (0.0) |
90 | 1 (12.5) | 0(0.0) | 0 (0.0) |
100 | 0 (0.0) | 0(0.0) | 0 (0.0) |
Primary Antibody (producer) | Clone | Dilution |
---|---|---|
Monoclonal mouse anti-human |
MIB-1 | RTU |
Monoclonal mouse primary |
4A4 | RTU |
Monoclonal mouse Primary |
Kip2 | 1:50 |
Partial Mole Characteristics | Absent or |
Complete |
---|---|---|
Two types of villi | absent |
8 (100.0) |
Irregular villus contours | absent |
0(0.0) |
Trophoblastic stromal inclusions | absent |
7(87.5) |
Focal trophoblastic proliferation | absent |
7(87.5) |
Presence of fetal erythrocytes | absent |
8 (100.0) |